| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |